Institutional Ownership
Anika Therapeutics Inc
CUSIP 035255108COMANIKQ1 2026
Institutional Holders
125
13F filers
Shares Held
11.59M
Aggregate institutional
Institutional Value
$158.75M
Q1 2026
Net New Holders
+5
19 new · 14 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions19
Increased50
Decreased40
Sold out14
Institutional Holders
125 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 1.59M | $23.13M | −59.6K | Reduced |
| 2 | Caligan Partners LP | 1.44M | $20.81M | 0 | Held |
| 3 | Morgan Stanley | 872.1K | $12.64M | +99.8K | Added |
| 4 | Boothbay Fund Management, LLC | 529.5K | $7.68M | −5.0K | Reduced |
| 5 | Renaissance Technologies LLC | 502.2K | $7.28M | −13.5K | Reduced |
| 6 | Dimensional Fund Advisors LP | 458.8K | $6.65M | −35.5K | Reduced |
| 7 | Capital Management Corp /Va | 447.7K | $6.49M | −52.7K | Reduced |
| 8 | Deutsche Bank AG\ | 353.2K | $5.12M | +271.9K | Added |
| 9 | State Street Corp | 346.1K | $5.02M | +9.5K | Added |
| 10 | Geode Capital Management, LLC | 330.1K | $4.79M | +4.5K | Added |
115 more institutional holders on Premium
See every fund holding Anika Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders